Therapeutic development of mesenchymal stem cells or their extracellular vesicles to inhibit autoimmune-mediated inflammatory processes in systemic lupus erythematosus

Frontiers in Immunology

Volumn 8, Issue MAY, 2017, Pages

  Sharma, Juhi ^a   Hampton, Jeffrey M ^a   Valiente, Giancarlo R ^a   Wada, Takuma ^a   Steigelman, Holly ^a   Young, Matthew C ^b   Spurbeck, Rachel R ^c   Blazek, Alisa D ^c   Bösh, Steffi ^d   Jarjour, Wael N ^a   Young, Nicholas A ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b The Inflammation Foundation   (United States)

^c BATTELLE MEMORIAL INSTITUTE   (United States)

^d UNIVERSITÉ DE NANTES   (France)

Author keywords

Autoimmunity; Emerging therapies; Extracellular vesicles; Inflammation; Mesenchymal stem cells; Systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR;

AUTOIMMUNITY; CELL PROLIFERATION; CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE ACTIVITY SCORE; EXOSOME; GLOMERULONEPHRITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; MESENCHYMAL STEM CELL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 85020020819     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00526     Document Type: Short Survey

References (61)

1. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood (2007) 110:3499-506. doi:10.1182/blood-2007-02-069716
2. Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood (2005) 105(10):4120-6. doi:10.1182/blood-2004-02-0586
3. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells (2006) 24:74-85. doi:10.1634/stemcells.2004-0359
4. Blazquez R, Sanchez-Margallo FM, Alvarez V, Uson A, Casado JG. Surgical meshes coated with mesenchymal stem cells provide an anti-inflammatory environment by a M2 macrophage polarization. Acta Biomater (2016) 31:221-30. doi:10.1016/j.actbio.2015.11.057
5. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood (2005) 105(4):1815-22. doi:10.1182/blood-2004-04-1559
6. Maccario R, Podestà M, Moretta A, Cometa A, Comoli P, Montagna D, et al. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica (2005) 90(4):516-25
7. Gebler A, Zabel O, Seliger B. The immunomodulatory capacity of mesenchymal stem cells. Trends Mol Med (2012) 18(2):128-34. doi:10.1016/j.molmed.2011.10.004
8. Bellavia M, Altomare R, Cacciabaudo F, Santoro A, Allegra A, Concetta Gioviale M, et al. Towards an ideal source of mesenchymal stem cell isolation for possible therapeutic application in regenerative medicine. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2014) 158(3):356-60. doi:10.5507/bp.2013.051
9. Huang GT, Gronthos S, Shi S. Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J Dent Res (2009) 88(9):792-806. doi:10.1177/0022034509340867
10. Tsokos GC. Systemic lupus erythematosus. N Engl J Med (2011) 365:2110-21. doi:10.1056/NEJMra1100359
11. Young NA, Friedman AK, Kaffenberger B, Rajaram MV, Birmingham DJ, Rovin BH, et al. Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosus. Mol Immunol (2013) 54:23-31. doi:10.1016/j.molimm.2012.10.026
12. Young NA, Wu LC, Burd CJ, Friedman AK, Kaffenberger BH, Rajaram MV, et al. Estrogen modulation of endosome-associated toll-like receptor 8: An IFNalpha-independent mechanism of sex-bias in systemic lupus erythematosus. Clin Immunol (2014) 151(1):66-77. doi:10.1016/j.clim.2014.01.006
13. Jordan NP, D'Cruz DP. Efficacy, pharmacokinetic and pharmacodynamic profile of belimumab for systemic lupus erythematosus. Expert Opin Drug Metab Toxicol (2015) 11:1635-45. doi:10.1517/17425255.2015.1077808
14. Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, et al. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells (2009) 27:1421-32. doi:10.1002/stem.68
15. Ma X, Che N, Gu Z, Huang J, Wang D, Liang J, et al. Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation. Cell Transplant (2013) 22:2279-90. doi:10.3727/096368912X658692
16. Jang E, Jeong M, Kim S, Jang K, Kang BK, Lee DY, et al. Infusion of human bone marrow-derived mesenchymal stem cells alleviates autoimmune nephritis in a lupus model by suppressing follicular helper T-cell development. Cell Transplant (2016) 25(1):1-15. doi:10.3727/096368915X688173
17. Wang D, Li J, Zhang Y, Zhang M, Chen J, Li X, et al. Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study. Arthritis Res Ther (2014) 16:R79. doi:10.1186/ar4520
18. Wang D, Zhang H, Liang J, Li X, Feng X, Wang H, et al. Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplant (2013) 22:2267-77. doi:10.3727/096368911X582769
19. Asami T, Ishii M, Fujii H, Namkoong H, Tasaka S, Matsushita K, et al. Modulation of murine macrophage TLR7/8-mediated cytokine expression by mesenchymal stem cell-conditioned medium. Mediators Inflamm (2013) 2013:264260. doi:10.1155/2013/264260
20. Lai RC, Arslan F, Lee MM, Sze NSK, Choo A, Chen TS, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res (2010) 4(3):214-22. doi:10.1016/j.scr.2009.12.003
21. Lötvall J, Hill AF, Hochberg F, Buzás EI, Di Vizio D, Gardiner C, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles (2014) 3:26913. doi:10.3402/jev.v3.26913
22. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol (2013) 200:373-83. doi:10.1083/jcb.201211138
23. Pan BT, Johnstone RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell (1983) 33:967-78. doi:10.1016/0092-8674(83)90040-5
24. Robbins PD, Dorronsoro A, Booker CN. Regulation of chronic inflammatory and immune processes by extracellular vesicles. J Clin Invest (2016) 126:1173-80. doi:10.1172/JCI81131
25. Lamparski HG, Metha-Damani A, Yao JY, Patel S, Hsu DH, Ruegg C, et al. Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods (2002) 270:211-26. doi:10.1016/S0022-1759(02)00330-7
26. Vallabhaneni KC, Penfornis P, Dhule S, Guillonneau F, Adams KV, Mo YY, et al. Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites. Oncotarget (2015) 6:4953-67. doi:10.18632/oncotarget.3211
27. Baglio SR, Pegtel DM, Baldini N. Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol (2012) 3:359. doi:10.3389/fphys.2012.00359
28. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 9(6):654-9. doi:10.1038/ncb1596
29. Young NA, Valiente GR, Hampton JM, Wu LC, Burd CJ, Willis WL, et al. Estrogen-regulated STAT1 activation promotes TLR8 expression to facilitate signaling via microRNA-21 in systemic lupus erythematosus. Clin Immunol (2016) 176:12-22. doi:10.1016/j.clim.2016.12.005
30. Salama A, Fichou N, Allard M, Dubreil L, De Beaurepaire L, Viel A, et al. MicroRNA-29b modulates innate and antigen-specific immune responses in mouse models of autoimmunity. PLoS One (2014) 9:e106153. doi:10.1371/journal.pone.0106153
31. Ahmadbeigi N, Shafiee A, Seyedjafari E, Gheisari Y, Vassei M, Amanpour S, et al. Early spontaneous immortalization and loss of plasticity of rabbit bone marrow mesenchymal stem cells. Cell Prolif (2011) 44(1):67-74. doi:10.1111/j.1365-2184.2010.00731.x
32. Furlani D, Li W, Pittermann E, Klopsch C, Wang L, Knopp A, et al. A transformed cell population derived from cultured mesenchymal stem cells has no functional effect after transplantation into the injured heart. Cell Transplant (2009) 18(3):319-31. doi:10.3727/096368909788534906
33. Zhou YF, Bosch-Marce M, Okuyama H, Krishnamachary B, Kimura H, Zhang L, et al. Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. Cancer Res (2006) 66:10849-54. doi:10.1158/0008-5472.CAN-06-2146
34. Omel'chenko DO, Rzhaninova AA, Gol'dshtein DV. [Comparative transcriptome pairwise analysis of spontaneously transformed multipotent stromal cells from human adipose tissue]. Genetika (2014) 50:106-15. doi:10.1134/S1022795414010098
35. Casiraghi F, Remuzzi G, Abbate M, Perico N. Multipotent mesenchymal stromal cell therapy and risk of malignancies. Stem Cell Rev (2013) 9(1):65-79. doi:10.1007/s12015-011-9345-4
36. Torsvik A, Rosland GV, Svendsen A, Molven A, Immervoll H, McCormack E, et al. Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter. Cancer Res (2010) 70(15):6393-6. doi:10.1158/0008-5472.CAN-10-1305
37. Najar M, Rouas R, Raicevic G, Boufker HI, Lewalle P, Meuleman N, et al. Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. Cytotherapy (2009) 11:570-83. doi:10.1080/14653240903079377
38. Carrion F, Nova E, Luz P, Apablaza F, Figueroa F. Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation. Immunol Lett (2011) 135(1-2):10-6. doi:10.1016/j.imlet.2010.09.006
39. Siegel G, Kluba T, Hermanutz-Klein U, Bieback K, NorthoffH, Schäfer R. Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells. BMC Med (2013) 11:146. doi:10.1186/1741-7015-11-146
40. Whitfield MJ, Lee WC, Van Vliet KJ. Onset of heterogeneity in culture-expanded bone marrow stromal cells. Stem Cell Res (2013) 11:1365-77. doi:10.1016/j.scr.2013.09.004
41. Jones E, Schafer R. Biological differences between native and cultured mesenchymal stem cells: implications for therapies. Methods Mol Biol (2015) 1235:105-20. doi:10.1007/978-1-4939-1785-3_10
42. Ray SS, Pramanik K, Sarangi SK, Jain N. Serum-free non-toxic freezing solution for cryopreservation of human adipose tissue-derived mesenchymal stem cells. Biotechnol Lett (2016) 38:1397-404. doi:10.1007/s10529-016-2111-6
43. Hubel A. Advancing the preservation of cellular therapy products. Transfusion (2011) 51(Suppl 4):82S-6S. doi:10.1111/j.1537-2995.2011.03370.x
44. Nossent J, Cikes N, Kiss E, Marchesoni A, Nassonova V, Mosca M, et al. Current causes of death in systemic lupus erythematosus in Europe, 2000-2004: relation to disease activity and damage accrual. Lupus (2007) 16(5):309-17. doi:10.1177/0961203307077987
45. EL Andaloussi S, Mager I, Breakefield XO, Wood MJ. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov (2013) 12:347-57. doi:10.1038/nrd3978
46. Mokarizadeh A, Delirezh N, Morshedi A, Mosayebi G, Farshid AA, Mardani K. Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling. Immunol Lett (2012) 147:47-54. doi:10.1016/j.imlet.2012.06.001
47. Budoni M, Fierabracci A, Luciano R, Petrini S, Di Ciommo V, Muraca M. The immunosuppressive effect of mesenchymal stromal cells on B lymphocytes is mediated by membrane vesicles. Cell Transplant (2013) 22(2):369-79. doi:10.3727/096368911X582769
48. Yeo RW, Lai RC, Zhang B, Tan SS, Yin Y, Teh BJ, et al. Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. Adv Drug Deliv Rev (2013) 65:336-41. doi:10.1016/j.addr.2012.07.001
49. Bruno S, Grange C, Collino F, Deregibus MC, Cantaluppi V, Biancone L, et al. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS One (2012) 7(3):e33115. doi:10.1371/journal.pone.0033115
50. Zhang S, Chu WC, Lai RC, Lim SK, Hui JH, Toh WS. Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. Osteoarthritis Cartilage (2016) 24:2135-40. doi:10.1016/j.joca.2016.06.022
51. Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J, Doeppner TR, et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia (2014) 28(4):970-3. doi:10.1038/leu.2014.41
52. Bosch S, de Beaurepaire L, Allard M, Mosser M, Heichette C, Chrétien D, et al. Trehalose prevents aggregation of exosomes and cryodamage. Sci Rep (2016) 6:36162. doi:10.1038/srep36162
53. Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol (2014) 32(3):252-60. doi:10.1038/nbt.2816
54. Kivity S, Agmon-Levin N, Zandman-Goddard G, Chapman J, Shoenfeld Y. Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Med (2015) 13:43. doi:10.1186/s12916-015-0269-8
55. Lener T, Gimona M, Aigner L, Börger V, Buzas E, Camussi G, et al. Applying extracellular vesicles based therapeutics in clinical trials-an ISEV position paper. J Extracell Vesicles (2015) 4:30087. doi:10.3402/jev.v4.30087
56. Witwer KW, Buzas EI, Bemis LT, Bora A, Lasser C, Lotvall J, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles (2013) 2. doi:10.3402/jev.v2i0.20360
57. Lai RC, Yeo RW, Padmanabhan J, Choo A, de Kleijn DP, Lim SK. Isolation and characterization of exosome from human embryonic stem cell-derived c-myc-immortalized mesenchymal stem cells. Methods Mol Biol (2016) 1416:477-94. doi:10.1007/978-1-4939-3584-0_29
58. Momen-Heravi F, Balaj L, Alian S, Mantel PY, Halleck AE, Trachtenberg AJ, et al. Current methods for the isolation of extracellular vesicles. Biol Chem (2013) 394(10):1253-62. doi:10.1515/hsz-2013-0141
59. Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell (2012) 151:1542-56. doi:10.1016/j.cell.2012.11.024
60. Sitar S, Kejžar A, Pahovnik D, Kogej K, Tušek-Žnidaric M, Lenassi M, et al. Size characterization and quantification of exosomes by asymmetrical-flow field-flow fractionation. Anal Chem (2015) 87:9225-33. doi:10.1021/acs.analchem.5b01636
61. Young NA, Wu LC, Bruss M, Kaffenberger BH, Hampton J, Bolon B, et al. A chimeric human-mouse model of Sjogren's syndrome. Clin Immunol (2014) 156(1):1-8. doi:10.1016/j.clim.2014.10.004